PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.02%
Revenue growth at 50-75% of MU's 8.06%. Martin Whitman would worry about competitiveness or product relevance.
7.03%
Gross profit growth at 50-75% of MU's 13.96%. Martin Whitman would question if cost structure or brand is lagging.
10.15%
EBIT growth 50-75% of MU's 15.18%. Martin Whitman would suspect suboptimal resource allocation.
10.59%
Operating income growth at 50-75% of MU's 15.18%. Martin Whitman would doubt the firm’s ability to compete efficiently.
2.86%
Net income growth under 50% of MU's 23.56%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.62%
EPS growth under 50% of MU's 21.19%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.70%
Diluted EPS growth under 50% of MU's 21.92%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.61%
Share reduction while MU is at 1.94%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.80%
Reduced diluted shares while MU is at 1.06%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.21%
Dividend reduction while MU stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
64.21%
OCF growth above 1.5x MU's 19.58%. David Dodd would confirm a clear edge in underlying cash generation.
70.86%
FCF growth above 1.5x MU's 33.61%. David Dodd would verify if the firm’s strategic investments yield superior returns.
61.96%
10Y revenue/share CAGR under 50% of MU's 261.42%. Michael Burry would suspect a lasting competitive disadvantage.
48.84%
5Y revenue/share CAGR under 50% of MU's 210.91%. Michael Burry would suspect a significant competitive gap or product weakness.
31.55%
3Y revenue/share CAGR under 50% of MU's 63.94%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
375.35%
10Y OCF/share CAGR under 50% of MU's 930.21%. Michael Burry would worry about a persistent underperformance in cash creation.
205.86%
Below 50% of MU's 1533.09%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
135.70%
3Y OCF/share CAGR at 50-75% of MU's 222.91%. Martin Whitman would suspect weaker recent execution or product competitiveness.
222.83%
Net income/share CAGR at 50-75% of MU's 384.55%. Martin Whitman might question if the firm’s product or cost base lags behind.
140.33%
Below 50% of MU's 1116.87%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
113.67%
Below 50% of MU's 229.15%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
43.90%
Below 50% of MU's 154.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
8.47%
Below 50% of MU's 212.33%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.29%
Below 50% of MU's 92.13%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.27%
Dividend/share CAGR of 520.27% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
121.41%
Dividend/share CAGR of 121.41% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
81.19%
3Y dividend/share CAGR of 81.19% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.67%
AR growth is negative/stable vs. MU's 14.47%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.85%
Inventory growth well above MU's 0.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.83%
Asset growth at 50-75% of MU's 10.95%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
0.54%
BV/share growth of 0.54% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
24.23%
Debt growth far above MU's 2.95%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.26%
Our R&D shrinks while MU invests at 16.74%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.85%
SG&A growth well above MU's 2.62%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.